Pacira Biosciences
Pacira BioSciences Inc is an American commercial-stage specialty pharmaceutical enterprise headquartered in Tampa, Florida. The company specializes in the development, manufacturing, and commercialization of non-opioid pain management and regenerative health solutions, anchored by its proprietary DepoFoam drug delivery technology utilized in products such as Exparel. Principal revenue is derived through commercial pharmaceutical product sales of approved non-opioid medications to hospitals and surgical centers. Pacira BioSciences is publicly listed on the Nasdaq Stock Market.
3 of the funds FundTelligence covers report a position in Pacira Biosciences.
- Legal name
- Pacira Biosciences Inc
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 3
Funds holding Pacira Biosciences
- KLP AksjeGlobal Small Cap Flerfaktor — KLP · 0.37 % (full portfolio disclosed, June 2026)
- BlackRock iShares NASDAQ US Biotechnology UCITS ETF — BlackRock · 0.09 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)